Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
5 clinical trials · Condition
◉ Watch Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
| Record | Firm | Date |
|---|---|---|
| A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia (NCT03589326) | Takeda | 2018-10-04 |
| ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML (NCT03595917) | Marlise Luskin, MD | 2018-07-24 |
| Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders. (NCT01066468) | Novartis Pharmaceuticals | 2010-10-01 |
| Expanded Access Program of Ponatinib (NCT01592136) | Ariad Pharmaceuticals |
Track Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) automatically
Every clearance here is in the API, with alerts when new ones post.